These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 24025401)
81. Curcumin against hepatitis C virus infection: spicing up antiviral therapies with 'nutraceuticals'? Pécheur EI Gut; 2014 Jul; 63(7):1035-7. PubMed ID: 24092864 [No Abstract] [Full Text] [Related]
82. New targets for treatment against HCV infection. Pan Q; van der Laan LJ Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):505-15. PubMed ID: 23199508 [TBL] [Abstract][Full Text] [Related]
84. Synthesis and anti-HCV entry activity studies of β-cyclodextrin-pentacyclic triterpene conjugates. Xiao S; Wang Q; Si L; Shi Y; Wang H; Yu F; Zhang Y; Li Y; Zheng Y; Zhang C; Wang C; Zhang L; Zhou D ChemMedChem; 2014 May; 9(5):1060-70. PubMed ID: 24623716 [TBL] [Abstract][Full Text] [Related]
85. Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents. Magri A; Reilly R; Scalacci N; Radi M; Hunter M; Ripoll M; Patel AH; Castagnolo D Bioorg Med Chem Lett; 2015 Nov; 25(22):5372-6. PubMed ID: 26428870 [TBL] [Abstract][Full Text] [Related]
86. Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates. Shigeta S; Mori S; Kodama E; Kodama J; Takahashi K; Yamase T Antiviral Res; 2003 May; 58(3):265-71. PubMed ID: 12767474 [TBL] [Abstract][Full Text] [Related]
87. HIV-protease inhibitors block the replication of both vesicular stomatitis and influenza viruses at an early post-entry replication step. Federico M Virology; 2011 Aug; 417(1):37-49. PubMed ID: 21620431 [TBL] [Abstract][Full Text] [Related]
88. Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor. Mata MA; Satterly N; Versteeg GA; Frantz D; Wei S; Williams N; Schmolke M; Peña-Llopis S; Brugarolas J; Forst CV; White MA; García-Sastre A; Roth MG; Fontoura BM Nat Chem Biol; 2011 Sep; 7(10):712-9. PubMed ID: 21909097 [TBL] [Abstract][Full Text] [Related]
89. Aspirin inhibits hepatitis C virus entry by downregulating claudin-1. Yin P; Zhang L J Viral Hepat; 2016 Jan; 23(1):62-4. PubMed ID: 26289738 [TBL] [Abstract][Full Text] [Related]
90. The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses. Pécheur EI; Borisevich V; Halfmann P; Morrey JD; Smee DF; Prichard M; Mire CE; Kawaoka Y; Geisbert TW; Polyak SJ J Virol; 2016 Jan; 90(6):3086-92. PubMed ID: 26739045 [TBL] [Abstract][Full Text] [Related]
91. [Screening 20 Chinese herbs often used for clearing heat and dissipating toxin with nude mice model of hepatitis C viral infection]. Tang ZM; Peng M; Zhan CJ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Jun; 23(6):447-8. PubMed ID: 12872400 [TBL] [Abstract][Full Text] [Related]
92. Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study. El-Fakharany EM; Sánchez L; Al-Mehdar HA; Redwan EM Virol J; 2013 Jun; 10():199. PubMed ID: 23782993 [TBL] [Abstract][Full Text] [Related]
93. Anti-Hepatitis C Virus Activity of Uridine Derivatives of 2-Deoxy Sugars. Krol E; Wandzik I; Pastuch-Gawolek G; Szewczyk B Molecules; 2018 Jun; 23(7):. PubMed ID: 29954068 [TBL] [Abstract][Full Text] [Related]
94. Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors. Xiao S; Wang Q; Si L; Zhou X; Zhang Y; Zhang L; Zhou D Eur J Med Chem; 2016 Nov; 124():1-9. PubMed ID: 27565552 [TBL] [Abstract][Full Text] [Related]
95. Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening. Yu X; Uprichard SL Curr Protoc Microbiol; 2010 Aug; Chapter 17(1):Unit 17.5.. PubMed ID: 20812217 [TBL] [Abstract][Full Text] [Related]
96. In Vitro Exploration of the Anti-HCV Potential of the Synthetic Spacer Peptides Derived from Human, Bovine, and Camel Lactoferrins. Albar AH; El-Fakharany EM; Almehdar HA; Uversky VN; Redwan EM Protein Pept Lett; 2017; 24(10):909-921. PubMed ID: 27834141 [TBL] [Abstract][Full Text] [Related]
97. Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus. Montero A; Gastaminza P; Law M; Cheng G; Chisari FV; Ghadiri MR Chem Biol; 2011 Nov; 18(11):1453-62. PubMed ID: 22118679 [TBL] [Abstract][Full Text] [Related]
98. Antiviral activity of substituted salicylanilides--a review. Krátký M; Vinšová J Mini Rev Med Chem; 2011 Oct; 11(11):956-67. PubMed ID: 21762100 [TBL] [Abstract][Full Text] [Related]
99. An Engineered Microvirin Variant with Identical Structural Domains Potently Inhibits Human Immunodeficiency Virus and Hepatitis C Virus Cellular Entry. Shahid M; Qadir A; Yang J; Ahmad I; Zahid H; Mirza S; Windisch MP; Shahzad-Ul-Hussan S Viruses; 2020 Feb; 12(2):. PubMed ID: 32054060 [TBL] [Abstract][Full Text] [Related]
100. [Oxymatrine inhibits target cell infection in the HCVcc system]. Chen N; Liu YH; Liu XJ; Chen YR; Guo YH; Liu M Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):40-5. PubMed ID: 26983388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]